Trifluoroacetic acid → 3-(6-Fluoro-1,3-benzoxazol-2-yl)-5-[1-(4-piperidyl)pyrazol-4-yl]pyrazin-2-amine
Reaction equation
[NH2:1][C:2]1[N:3]=[CH:4][C:5]([C:18]2[CH:19]=[N:20][N:21]([CH:23]3[CH2:28][CH2:27][N:26](C(OC(C)(C)C)=O)[CH2:25][CH2:24]3)[CH:22]=2)=[N:6][C:7]=1[C:8]1[O:9][C:10]2[CH:16]=[C:15]([F:17])[CH:14]=[CH:13][C:11]=2[N:12]=1.C(O)(C(F)(F)F)=O>>[F:17][C:15]1[CH:14]=[CH:13][C:11]2[N:12]=[C:8]([C:7]3[C:2]([NH2:1])=[N:3][CH:4]=[C:5]([C:18]4[CH:19]=[N:20][N:21]([CH:23]5[CH2:24][CH2:25][NH:26][CH2:27][CH2:28]5)[CH:22]=4)[N:6]=3)[O:9][C:10]=2[CH:16]=1Participants
3
Procedure
Using analogous procedures to those described in Example 17, tert-butyl 4-[4-[5-amino-6-(6-fluoro-1,3-benzoxazol-2-yl)pyrazin-2-yl]pyrazol-1-yl]piperidine-1-carboxylate (100 mg) was reacted with TFA to give 3-(6-fluoro-1,3-benzoxazol-2-yl)-5-[1-(4-piperidyl)pyrazol-4-yl]pyrazin-2-amine (46 mg). NMR Spectrum: (400 MHz, MeOD) 8.60 (s, 1H), 8.35 (s, 1H), 8.20 (s, 1H), 7.90 (dd, 1H), 7.60 (dd, 1H), 7.30 (dd, 1H), 4.20 (m, 1H), 3.70 (m, 1H), 3.30 (m, 2H), 2.50 (m, 4H); Mass spectrum: M+H+ 380
Sources & evidence
- ORD record
- ord-1849d5d6f7aa4900837d048f0a10d8a3
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08017611B2
Reaction notes
Loading…